ARCH Venture Fund IX Overage, L.P.'s Net Worth
Estimate Recalculated Apr 2, 2025 08:06PM EST
Who is ARCH Venture Fund IX Overage, L.P.
ARCH Venture Fund IX Overage, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Lyell Immunopharma, Inc., Gossamer Bio, Inc., Karuna Therapeutics, Inc., Vir Biotechnology, Inc., Beam Therapeutics Inc., and Boundless Bio, Inc..
SEC CIK
ARCH Venture Fund IX Overage, L.P.'s CIK is 0001666307
Past Insider Trading and Trends
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
